HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryutaro Fukui Selected Research

Phosphotransferases (Kinase)

10/2018Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2 axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryutaro Fukui Research Topics

Disease

4Inflammation (Inflammations)
10/2021 - 07/2011
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 08/2012
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2018
1Bites and Stings (Sting)
10/2021
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2021
1Disease Progression
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019
1Infections
10/2018
1Hepatitis
01/2018
1Massive Hepatic Necrosis
01/2017
1Cytokine Release Syndrome
01/2017
1Colitis
06/2013
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2011
1Sepsis (Septicemia)
11/2007

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2013
3Nucleic AcidsIBA
10/2021 - 08/2012
2InterferonsIBA
10/2021 - 06/2013
2Toll-Like Receptor 7IBA
01/2021 - 07/2011
2Double-Stranded RNA (RNA, Double Stranded)IBA
10/2018 - 06/2013
2Toll-Like Receptor 9IBA
01/2017 - 01/2013
2LigandsIBA
01/2017 - 01/2016
1RNA (Ribonucleic Acid)IBA
10/2021
1immune RNA (I-RNA)IBA
01/2021
1AutoantibodiesIBA
01/2021
1Azacitidine (5 Azacytidine)FDA Link
01/2019
1Phosphotransferases (Kinase)IBA
10/2018
1ChemokinesIBA
10/2018
1Mechanistic Target of Rapamycin Complex 2IBA
10/2018
1GalactosamineIBA
01/2017
1nasIBA
08/2012
1Proteasome InhibitorsIBA
01/2011
1LipopolysaccharidesIBA
11/2007

Therapy/Procedure

1Therapeutics
01/2019